CrystalGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 02:03 am
Share
CrystalGenomics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 113.6 million compared to KRW 136.5 million a year ago. Net loss was KRW 771.14 million compared to net income of KRW 15,094.36 million a year ago.
For the nine months, sales was KRW 295.71 million compared to KRW 348.19 million a year ago. Net income was KRW 363.15 million compared to KRW 5,785.83 million a year ago.
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.